Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX: 4747)
Taiwan
· Delayed Price · Currency is TWD 69.10
-1.00 (-1.43%)
Nov 22, 2024, 1:30 PM CST
Johnson Chemical Pharmaceutical Works Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 81.83 | 79.7 | 64.85 | 49.1 | 63.56 | 64.47 | Upgrade
|
| Depreciation & Amortization | 21.39 | 21.11 | 18.27 | 15.29 | 13.23 | 12.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.01 | - | 0.01 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.22 | -0.15 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 6.38 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.56 | 0.09 | 0.88 | - | -0.48 | 0.06 | Upgrade
|
| Other Operating Activities | -8 | 8.13 | 3.42 | 4.97 | -2.4 | 3.22 | Upgrade
|
| Change in Accounts Receivable | 12.2 | -4.87 | -23.76 | -2.49 | 14.62 | -14.08 | Upgrade
|
| Change in Inventory | -6.4 | -11.78 | 19.45 | 11.44 | -24.48 | 1.47 | Upgrade
|
| Change in Accounts Payable | -15.46 | 34.5 | -1.67 | -17.03 | 7.57 | 1.72 | Upgrade
|
| Change in Unearned Revenue | 2.44 | 0.29 | -1.33 | 3.51 | -2.47 | 3.18 | Upgrade
|
| Change in Other Net Operating Assets | -5.34 | 3.56 | 9.58 | -12.46 | 2.61 | -0.67 | Upgrade
|
| Operating Cash Flow | 83.32 | 136.95 | 89.69 | 52.35 | 71.77 | 71.52 | Upgrade
|
| Operating Cash Flow Growth | -31.61% | 52.70% | 71.33% | -27.07% | 0.36% | 4.94% | Upgrade
|
| Capital Expenditures | -25.26 | -33.12 | -59.71 | -37.29 | -162.18 | -15.08 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | 0.63 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -6.93 | Upgrade
|
| Other Investing Activities | 0.04 | -0.17 | -0.21 | -0.86 | -0.06 | -0.25 | Upgrade
|
| Investing Cash Flow | -25.23 | -33.28 | -59.92 | -38.15 | -161.61 | -22.26 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 130 | - | Upgrade
|
| Long-Term Debt Issued | - | 395.36 | - | - | - | - | Upgrade
|
| Total Debt Issued | - | 395.36 | - | - | 130 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -20 | -50 | - | - | Upgrade
|
| Total Debt Repaid | - | - | -20 | -50 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 395.36 | -20 | -50 | 130 | - | Upgrade
|
| Issuance of Common Stock | - | 480 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -67.32 | -60.04 | -43.53 | -57.64 | -54.03 | -49.53 | Upgrade
|
| Other Financing Activities | -0.15 | 0.15 | - | - | - | - | Upgrade
|
| Financing Cash Flow | -67.47 | 815.47 | -63.53 | -107.64 | 75.97 | -49.53 | Upgrade
|
| Net Cash Flow | -9.38 | 919.14 | -33.76 | -93.44 | -13.87 | -0.28 | Upgrade
|
| Free Cash Flow | 58.06 | 103.84 | 29.98 | 15.06 | -90.41 | 56.44 | Upgrade
|
| Free Cash Flow Growth | -41.41% | 246.36% | 99.09% | - | - | -7.21% | Upgrade
|
| Free Cash Flow Margin | 9.39% | 17.11% | 6.06% | 3.66% | -21.32% | 13.27% | Upgrade
|
| Free Cash Flow Per Share | 1.25 | 2.73 | 1.00 | 0.50 | -3.00 | 1.87 | Upgrade
|
| Cash Interest Paid | 1.54 | 1.42 | 1.06 | 1.2 | 0.67 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 34.34 | 16.23 | 13.27 | 7.74 | 15.54 | 13.75 | Upgrade
|
| Levered Free Cash Flow | 31.01 | 80.62 | 15.88 | 9.92 | -106.25 | 44.96 | Upgrade
|
| Unlevered Free Cash Flow | 33.34 | 83.49 | 16.54 | 10.59 | -105.75 | 44.98 | Upgrade
|
| Change in Net Working Capital | 23.22 | -27.35 | -6.86 | 6.34 | 4.31 | 1.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.